Skye Bioscience Company Insiders

Skye Bioscience Management Team Effectiveness

The company has return on total asset (ROA) of (0.5488) % which means that it has lost $0.5488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9431) %, meaning that it created substantial loss on money invested by shareholders. Skye Bioscience's management efficiency ratios could be used to measure how well Skye Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. As of February 12, 2026, Return On Tangible Assets is expected to decline to -0.35. The current year's Return On Capital Employed is expected to grow to -0.38. At present, Skye Bioscience's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 65.1 K, whereas Return On Tangible Assets are forecasted to decline to (0.35). The current year's Common Stock Shares Outstanding is expected to grow to about 45.8 M, whereas Net Loss is forecasted to decline to (8.1 M). Skye Bioscience Common shows a total of 32.06 Million outstanding shares. Over half of Skye Bioscience's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Skye Bioscience in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Skye Bioscience, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Skye Bioscience Workforce Comparison

Skye Bioscience Insider Trading

Skye Bioscience Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Skye Bioscience Common often depends on how effective the management is. Skye Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Skye management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Skye management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Skye Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Skye Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Skye Bioscience's management manipulating its earnings.

When running Skye Bioscience's price analysis, check to measure Skye Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience is operating at the current time. Most of Skye Bioscience's value examination focuses on studying past and present price action to predict the probability of Skye Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience's price. Additionally, you may evaluate how the addition of Skye Bioscience to your portfolios can decrease your overall portfolio volatility.